Navigation Links
Bush Supports Restriction to ‘Morning–After’ Pll

Restricted access to emergency contraception for minors has been supported by President George W. Bush on Monday while drug regulators weigh wider access to the "morning-after"// pill.

Bush’s statement on this politically charged issue, has delayed a Senate confirmation vote on his nominee Andrew von Eschenbach to head the U.S Food and Drug Administration.

Von Eschenbach, as acting FDA commissioner has supported nonprescription emergency contraception sales for adults which earned him the opposition of some conservatives. Bush said, "I believe that Plan B ought to require a prescription for minors. That's what I believe."

Barr Pharmaceutical’s two attempts to win government approval to sell its Plan B drug widely without a prescription have been unsuccessful. In 2003 it applied for approval of the drug for all women of all ages but was rejected. In its second attempt approval for women 16 and older was applied. FDA has postponed its decision.

Democrats who assert that the decision on Plan B has been delayed for political reasons has held up Von Eschenbach's nomination to the permanent job of commissioner up for months.

According to Von Eschenbach Plan B could be used safely and effectively for women 18 and older provided younger people could not buy it without a doctor's note.

Plan B was approved as a prescription drug in 1999. It is a set of two high-dose hormone pills which can prevent pregnancy provided it is taken within 72 hours of sexual intercourse.

Supporters of the wide access to the drug include the American Medical Association and Planned Parenthood who say that easing access to the drug would lead to fewer abortions, but opponents argue it will spur promiscuity. Planned Parenthood President Cecile Richards said, "If the president's comments are an indication that they're final going to move on this, this would be great progress."

Von Eschenbach and two previous co mmissioners said that they were not directed by the White House on the issue. However the Family Research Council and other conservative groups which usually support Bush are opposing the nomination because von Eschenbach is moving ahead on Plan B, as well as continuing to allow the abortion pill RU-486 to remain on the market.

The group's vice president for government affairs, Tom McClusky, said, "Dr. von Eschenbach has shown a history of ignoring any concern for women's health in exchange for political expediency."

The FDA said that Plan B mainly worked by blocking the release of an egg from an ovary. The drug may also prevent the union of an egg and sperm. However RU-486 works by blocking a hormone which keeps a fertilized egg implanted in the uterus.
'"/>




Related medicine news :

1. Google Supports Indians Novel Literacy Drive
2. Actor Anil Kapoor Supports Birth Registration Cause
3. AMA Supports Tax Penalty for Uninsured Americans
4. Church Supports HIV Test Before Marriage
5. EHRVA Supports EHR Product Certification
6. AMA Supports Hospital Junk Food Review
7. Ontario Supports OHIP’s Rejection of Claim by North York Ma
8. Minister Supports Private Sector In NHS
9. FDA Imposes New Restrictions On Roches Accutane
10. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
11. Bird Flu Restrictions To Be Lifted In Scotland
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... , ... February 05, 2016 , ... Love is in ... in a variety of colors, assortments and packaging. This staple for Valentine’s Day is ... Kullen location. , For Valentine’s Day, not only are long-stem roses available, but ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchisees of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a ... and adults with muscular dystrophy, ALS and related diseases that severely limit strength ...
(Date:2/5/2016)... ... 05, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Tasting Event at the La Gorce Country Club in Miami Beach on March ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 05, 2016 , ... Stuart Bentkover, MD, FACS is thrilled to ... the most effective tattoo removal today, Dr. Bentkover is the only doctor in Central ... the PicoSure has been approved by the Food and Drug Administration (FDA) as a ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... a medical devices company, is one of five recipients to ... Terry McAuliffe,s office. ivWatch will be receiving the STEM ... to be held at the Science Museum of ... that have made significant contributions to science. ... ivWatch ...
(Date:2/5/2016)... Feb. 5, 2016 ... of the "Global Musculoskeletal Partnering 2010-2016: ... profile to their offering. --> ... of the "Global Musculoskeletal Partnering 2010-2016: ... profile to their offering. --> ...
(Date:2/5/2016)... BEIJING , Feb. 5, 2016 ... ("Dehaier Medical" or the "Company"), which develops, markets ... products in China and ... restructuring plan which aims to concentrate the Company,s ... wearable sleep respiratory business and to focus more ...
Breaking Medicine Technology: